Integrates pharmacologic knowledge and clinical decision-making to manage pulmonary disease states and support tobacco cessation through evidence-based practices.
Introduces psychosocial and behavioral aspects of pharmacy practice, covering ethical decision-making, the pharmacist's role in public health, patient perspectives on medication use, and patient-pharmacist communication.
Recent recorded grades — Spring 2025: 3.87 GPA, 96.9% A/AB (n=127 letter grades); Spring 2026: 3.91 GPA, 97.7% A/AB (n=131 letter grades). Includes jointly taught sections.